SCHEMBL22905022

SCHEMBL22905022

CCOC(=O)c1sc2cccc(Cl)c2c1-c1nc2ccc(C(N)=O)cc2n1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ CHEK2 O96017 1/20 0.45
▸ STING1 Q86WV6 2/20 0.42
▸ PDE2A O00408 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ BMPR2 Q13873 1/20 0.38
▸ VDR P11473 3/20 0.38
▸ NR1H4 Q96RI1 3/20 0.38
▸ THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29693898 1.00 KDM4E (0.52) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL29443113 1.00 KDM4E (0.52) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL22904893 0.93 KDM4E (0.52) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL29443028 0.93 KDM4E (0.52) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL22904895 0.88 CHEK2 (0.48) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL29443061 0.88 CHEK2 (0.48) KDM4EALDH1A1MAPK1L3MBTL1CHEK2
SCHEMBL24772450 0.87 KDM4E (0.51) KDM4EALDH1A1MAPK1L3MBTL1STING1
SCHEMBL24771133 0.85 KDM4E (0.49) KDM4EALDH1A1MAPK1L3MBTL1STING1
SCHEMBL24771130 0.85 KDM4E (0.49) KDM4EALDH1A1MAPK1L3MBTL1NPC1
SCHEMBL22904894 0.81 MCL1 (0.43) KDM4EALDH1A1MAPK1L3MBTL1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617780-B2 Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting CTXT PTY LTD (AU) 2026-05-05 — — US disclosed
EP-3999184-B1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2023-09-20 — — EP disclosed
EP-3999184-B1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2023-09-20 — — EP disclosed
US-20220380354-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2022-12-01 — — US disclosed
CN-114206880-A Benzothiophene, thienopyridine, and thienopyrimidine derivatives for modulation of STING CTXT私人有限公司 2022-03-18 — — CN disclosed
WO-2021009362-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LIMITED (AU) 2021-01-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380354-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING STING1, CGAS, HRH2 KDM4E 2764/4885ALDH1A1 1890/4885MAPK1 2293/4885
US-12617780-B2 Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting STING1, CGAS, IRF3 KDM4E 1748/4885ALDH1A1 3931/4885MAPK1 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback